Here’s a breakdown of the key findings from the provided text, focusing on the role of APOE ε4 in neurodegenerative diseases and immune dysregulation:
Core Finding: APOE ε4 carriers across various neurodegenerative diseases (Alzheimer’s Disease (AD), Parkinson’s Disease Dementia (PDD), Frontotemporal Dementia (FTD), Parkinson’s Disease (PD), and Amyotrophic Lateral Sclerosis (ALS)) exhibit a consistent pattern of systemic proteomic changes indicative of pro-inflammatory immune dysregulation.
Specific Immune Involvement:
Infection-Related Pathways: APOE ε4 is enriched in pathways related to several infections (herpes, influenza A, hepatitis, measles, Epstein-Barr virus (EBV)).
Immune Cell Enrichment:
Innate Immune Cells: Highest enrichment in intermediate and non-classical monocytes.
Adaptive immune Cells: Highest enrichment in memory CD8 T cells, regulatory T (Treg) cells, and memory CD4 T cells. Also enrichment in γδ T cells and NK cells.
Liver involvement: Enrichment in Kupffer cells and hepatocytes.
Proteomic Signatures & Consistency:
Plasma Proteome: 58 plasma proteins associated with the APOE genotype were identified in healthy controls. Thes proteins can effectively distinguish between APOE ε4 carriers and non-carriers across different neurodegenerative diseases. This signature is consistent across sexes and racial groups.
CSF & Plasma Correlation: Proteomic changes observed in cerebrospinal fluid (CSF) are also reflected in the plasma of APOE ε4 carriers.
Brain Correlation: Peripheral proteomic changes are mirrored in the brains (specifically the dorsolateral prefrontal cortex – dlPFC) of APOE ε4 carriers.
Key Biological Processes Affected:
Viral processes: The most considerably enriched biological process in both plasma and CSF.
Other enriched processes: protein processing, cellular processes, DNA/RNA processes, and apoptosis.
In essence, the study suggests that APOE ε4 isn’t just linked to a single disease, but rather to a common underlying immune dysregulation that manifests across multiple neurodegenerative conditions. This dysregulation appears to involve both innate and adaptive immune responses, and is reflected in changes in both the CSF, plasma, and brain.
the provided search results ([1][2][3]) do not contain facts relevant to APOE ε4 or Alzheimer’s disease. Therefore,I cannot fulfill this request using the given information.